|
|||||
|
|

Academic publishing company John Wiley & Sons (NYSE:WLY) posted $396.8 million of revenue in Q2 CY2025, down 1.7% year on year. Its GAAP profit of $0.22 per share increased from -$0.03 in the same quarter last year.
Is now the time to buy WLY? Find out in our full research report (it’s free).
Wiley's first quarter was met with a negative market reaction, reflecting investor concerns despite the company delivering results generally in line with Wall Street expectations. Management highlighted that AI licensing and open access publishing were bright spots, but traditional professional publishing faced headwinds, particularly in consumer and retail channels. CEO Matthew Kissner pointed to a "landmark $20 million AI licensing project," and noted that recurring revenue streams from research journals continued to underpin the company's stability. CFO Craig Albright acknowledged the impact of seasonal and one-time factors, such as a tough comparison to last year and temporary consulting expenses, which contributed to muted profit growth.
Looking ahead, Wiley's management is focused on expanding its AI partnerships and driving operational improvements to support margin expansion. The company believes that continued growth in AI licensing and open access submissions will be critical, while also calling out potential risks in professional publishing tied to consumer demand. Kissner stated, “AI is a transformative opportunity, and we're moving decisively to capitalize,” while also cautioning that the evolving economic climate could affect certain segments. The company aims to leverage its content across a broader set of industry verticals, with early-stage recurring revenue in AI subscription models and a strategic push into the corporate R&D market.
Management attributed Q1 performance to robust AI licensing, strong open access growth, and operational discipline, while acknowledging professional publishing softness and temporary cost pressures.
Wiley expects growth to be driven by expanding AI partnerships, open access journal momentum, and cost management, while monitoring risks in consumer-facing segments.
Going forward, the StockStory team will monitor (1) the pace of AI licensing and integration into new platforms such as Anthropic’s Claude, (2) sustained growth in open access submissions and recurring journal revenue, and (3) stabilization or improvement in professional publishing and consumer channels. Effective cost management and execution of technology upgrades will also be key signposts for Wiley’s longer-term trajectory.
Wiley currently trades at $38.25, down from $39.80 just before the earnings. Is the company at an inflection point that warrants a buy or sell? Find out in our full research report (it’s free).
Donald Trump’s April 2025 "Liberation Day" tariffs sent markets into a tailspin, but stocks have since rebounded strongly, proving that knee-jerk reactions often create the best buying opportunities.
The smart money is already positioning for the next leg up. Don’t miss out on the recovery - check out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
| 14 hours | |
| Feb-10 | |
| Feb-06 | |
| Feb-05 | |
| Jan-22 | |
| Jan-21 | |
| Jan-21 | |
| Jan-15 | |
| Jan-13 | |
| Jan-05 | |
| Dec-21 | |
| Dec-17 | |
| Dec-17 | |
| Dec-11 | |
| Dec-10 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite